Compare OOMA & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OOMA | YDES |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 517.6M | 543.0M |
| IPO Year | 2015 | N/A |
| Metric | OOMA | YDES |
|---|---|---|
| Price | $20.02 | $2.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $18.77 | N/A |
| AVG Volume (30 Days) | ★ 314.1K | 312.1K |
| Earning Date | 05-27-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 188.46 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $114,490,000.00 | N/A |
| Revenue This Year | $20.35 | N/A |
| Revenue Next Year | $4.17 | N/A |
| P/E Ratio | $215.11 | ★ N/A |
| Revenue Growth | ★ 9.53 | N/A |
| 52 Week Low | $9.79 | $1.70 |
| 52 Week High | $21.96 | $25.00 |
| Indicator | OOMA | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 55.63 | 44.84 |
| Support Level | $10.78 | $2.14 |
| Resistance Level | $21.57 | $3.05 |
| Average True Range (ATR) | 0.88 | 0.32 |
| MACD | -0.10 | 0.07 |
| Stochastic Oscillator | 52.24 | 59.36 |
Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that delivers voice and collaboration features, including messaging, intelligent virtual attendants, and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.